180 Life Sciences Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? (Deficit) Equity (Details)

Stockholders’ (Deficit) Equity (Details) - USD ($)								3 Months Ended
Stockholders’ (Deficit) Equity (Details) - USD ($)	May 13, 2024	Mar. 31, 2024	Nov. 28, 2023	Sep. 07, 2023	Aug. 31, 2023	Aug. 09, 2023	Mar. 31, 2023	Mar. 31, 2024	Feb. 28, 2024	Feb. 16, 2024	Dec. 31, 2023	Apr. 30, 2023	Dec. 31, 2022	Jul. 31, 2022
Stockholders’ (Deficit) Equity [Line Items]
Aggregate shares of common stock						35,102
Pre-funded warrants			257,205
Common stock warrants to purchase			477,058		242,915
Purchase price per share (in Dollars per share)						$ 12.35
Net proceeds (in Dollars)						$ 2,700,000
Additional paid in capital (in Dollars)		$ 130,353,728				$ 300,000		$ 130,353,728			$ 130,117,209
Purchaser agreed to pay (in Dollars)			$ 830,769
Warrants exercise price (in Dollars per share)			$ 3.23
Dividend rate					0.00%
Exercise of warrants issued		852,772						852,772			534,719
Offering were exercised (in Dollars)					$ 489
Compensation expenses (in Dollars)								$ 236,063
General and administrative expenses (in Dollars)							$ 470,703	234,113
Research and development expenses (in Dollars)								1,950
Amortization of the Restricted Stock Shares (in Dollars)								255,048
Weighted average remaining vesting period		1 year 7 months 6 days
August 2023 Pre-Funded Warrants [Member]
Stockholders’ (Deficit) Equity [Line Items]
Pre-funded warrants						207,814
August 2023 Common Warrants [Member]
Stockholders’ (Deficit) Equity [Line Items]
Common stock warrants to purchase						242,915
Warrant [Member]
Stockholders’ (Deficit) Equity [Line Items]
Aggregrate gross proceeds (in Dollars)						$ 2,999,606
Black Scholes Option Model [Member]
Stockholders’ (Deficit) Equity [Line Items]
Share price (in Dollars per share)					$ 6.46
Exercise price (in Dollars per share)					$ 12.35							$ 15.77	$ 15.77
Expected term					5 years 2 months 19 days
Volatility rate					100.00%
Discount rate					4.29%
Aggregate difference (in Dollars)		$ 3,100,000						$ 3,100,000
Warrants [Member]
Stockholders’ (Deficit) Equity [Line Items]
Share price (in Dollars per share)							$ 557,421
Maximum [Member]
Stockholders’ (Deficit) Equity [Line Items]
Shares of common stock		24,736						24,736
Minimum [Member]
Stockholders’ (Deficit) Equity [Line Items]
Shares of common stock		223,679						223,679
Amendment to the August 2023 Offering [Member]
Stockholders’ (Deficit) Equity [Line Items]
Warrants exercise price (in Dollars per share)			$ 0.0019
Amendment to the August 2023 Offering [Member] \| Warrants to Purchase Common Stock [Member]
Stockholders’ (Deficit) Equity [Line Items]
Warrants exercise price (in Dollars per share)					$ 3.23
Amendment to the August 2023 Offering [Member] \| Black Scholes Option Model [Member]
Stockholders’ (Deficit) Equity [Line Items]
Exercise price (in Dollars per share)					3.23
Expected term								5 years 2 months 19 days
Discount rate								4.29%
Class K Special Voting Shares [Member]
Stockholders’ (Deficit) Equity [Line Items]
Number of shares								14
Class K Special Voting Shares [Member] \| Common Stock [Member]
Stockholders’ (Deficit) Equity [Line Items]
Number of shares								14
Nasdaq Capital Market [Member]
Stockholders’ (Deficit) Equity [Line Items]
Stockholders’ equity (in Dollars)								$ 2,500,000
Director [Member]
Stockholders’ (Deficit) Equity [Line Items]
Granted options for purchase of shares	2,500,000
Common Stock [Member]
Stockholders’ (Deficit) Equity [Line Items]
Share price (in Dollars per share)										$ 0.0001
Shares of common stock		734,262		1				734,262
Common stock warrants to purchase														16,138
Research and development expenses (in Dollars)							$ 86,718
Common Stock [Member] \| Black Scholes Option Model [Member]
Stockholders’ (Deficit) Equity [Line Items]
Share price (in Dollars per share)					$ 6.46
Exercise price (in Dollars per share)														$ 15.77
Volatility rate								100.00%
Dividend rate								0.00%
Common Stock [Member] \| Amendment to the August 2023 Offering [Member]
Stockholders’ (Deficit) Equity [Line Items]
Exercise of warrants issued		257,205						257,205	257,205
Restricted Stock [Member]
Stockholders’ (Deficit) Equity [Line Items]
Aggregate issuance date fair value (in Dollars)				$ 1
Common Stock [Member]
Stockholders’ (Deficit) Equity [Line Items]
Shares of common stock					477,058							82,668	135,339